Advertisement

Archives of Orthopaedic and Trauma Surgery

, Volume 128, Issue 10, pp 1183–1186 | Cite as

Elephantiasis nostras verrucosa complicated with chronic tibial osteomyelitis

  • Egemen TurhanEmail author
  • Ahmet Ege
  • Selcuk Keser
  • Ahmet Bayar
Orthopaedic Surgery

Abstract

Elephantiasis nostras verrucosa represents an infrequent clinical entity with cutaneous changes characterized by dermal fibrosis, hyperkeratotic verrucous and papillamotous lesions resulting from chronic non-filarial lymphedema secondary to infections, surgeries, tumor obstruction, radiation, congestive heart failure, and obesity. Although recurrent streptococcal lymphangitis is believed to play a critical role in the origin of elephantiasis nostras verrucosa, the exact pathogenesis of the disorder is not yet clear. Therapeutic efforts should aim to reduce lymph stasis, which will also lead to improvement of the cutaneous changes but unfortunately there is no specific treatment for advanced cases. In this report, we present a patient who was treated by below knee amputation as a result of elephantiasis nostras verrucosa complicated with chronic tibial osteomyelitis.

Keywords

Elephantiasis nostras verrucosa Tibial Osteomyelitis Amputation 

References

  1. 1.
    Vaccaro M et al (2000) Elephantiasis nostras verrucosa. Int J Dermatol 39:764–766PubMedCrossRefGoogle Scholar
  2. 2.
    Schissel DJ, Hivnor C, Elston DM (1998) Elephantiasis nostras verrucosa. Cutis 62(2):77–80PubMedGoogle Scholar
  3. 3.
    Routh HB (1992) Elephantiasis. Int J Dermatol 31:845–852PubMedCrossRefGoogle Scholar
  4. 4.
    Rowley MJ, Rapini RP (1992) Elephantiasis nostras. Cutis 49:91–96PubMedGoogle Scholar
  5. 5.
    Rudolph RI, Gross PR (1973) Elephantiasis nostras verrucosa of the panniculus. Arch Dermatol 108:832–834PubMedCrossRefGoogle Scholar
  6. 6.
    Lin P, Phillips T (2003) Vascular lesions: ulcers. In: Bologinia JL et al (eds) Dermatology. Mosby, London, p 1637Google Scholar
  7. 7.
    Saccoman S, Rifleman GT (1995) Elephantiasis nostras verrucosa. J Am Podiatr Med Assoc 85:265–267PubMedGoogle Scholar
  8. 8.
    Chernosky ME, Derbes VJ (1966) Elephantiasis nostras of the abdominal wall. Arch Dermatol 94:757–762PubMedCrossRefGoogle Scholar
  9. 9.
    Jensen LP (1991) Elephantiais nostras: a rare complication to erysipelas. Ugeskr Laeger 153:440–441PubMedGoogle Scholar
  10. 10.
    Yoho RM, Budny AM, Pea AS (2006) Elephantiasis nostras verrucosa. J Am Podiatr Med Assoc 96(5):442–444PubMedGoogle Scholar
  11. 11.
    Zouboulis CC et al (1992) Elephantiasis nostras verrucosa: beneficial effect of oral etretinate therapy. Br J Dermatol 127(4):411–416PubMedCrossRefGoogle Scholar
  12. 12.
    Boyd J, Sloan S, Meffert J (2004) Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene. J Drugs Dermatol 3(4):446–448PubMedGoogle Scholar
  13. 13.
    Iwao F et al (2004) Elephantiasis nostras verrusosa successfully treated by surgical debridement. Dermatol Surg 30(6):939–941PubMedCrossRefGoogle Scholar
  14. 14.
    Fernandiz I et al (2005) Elephantiasis nostras verrusosa successfully treated by surgical debridement. Dermatol Surg 31(6):731CrossRefGoogle Scholar
  15. 15.
    Schiff BL, Kern AB (1980) Elephantiasis nostras. Cutis 25(1):88–89PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Egemen Turhan
    • 1
    Email author
  • Ahmet Ege
    • 1
  • Selcuk Keser
    • 1
  • Ahmet Bayar
    • 1
  1. 1.School of Medicine, Department of Orthopaedics and TraumatologyMedicine Faculty of Zonguldak Karaelmas UniversityZonguldakTurkey

Personalised recommendations